Iridium 191m: notice of claimed investigational exemption for a new drug, 1981
Scope and Contents
Consists of documentation relating to studies in 51Cr-EDTA, Copper 62 Radiopharmeceuticals, Iridium-191m, Osmium-191, Positron Emission Tomography (PET), and Single-Photon Emission Computed Tomography (SPECT). This is concerned mainly with funding acquisition, protocol development, and reporting to funders, though some of the material relates to human study patient consent, and reporting on study results
Dates
- Other: 1981
Access
The collection is restricted for 20 years from date of the records' creation. Please consult the hospital archivist for further information.
Extent
From the Collection: 2.5 Linear Feet (2.5 cartons)
Language of Materials
English
Repository Details
Part of the Boston Children’s Hospital Archives Repository
300 Longwood Ave, Boston, MA 02115
Boston MA 02115 United States
(617) 355-5286
archives@childrens.harvard.edu